Effect of islet amyloid polypeptide on somatostatin inhibition of insulin secretion from isolated rat pancreatic islets

Regulatory Peptides

Volumn 72, Issue 1, 1997, Pages 61-67

  Wang, Feng ^a   Westermark, Gunilla ^b   Gasslander, Thomas ^b   Permert, Johan ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Insulin; Islet amyloid polypeptide (IAPP); Pancreatic islet; Somatostatin

Indexed keywords

AMYLOID; INSULIN; SOMATOSTATIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HORMONAL REGULATION; IMMUNOCYTOCHEMISTRY; INSULIN RELEASE; NONHUMAN; PANCREAS ISLET; PRIORITY JOURNAL; RAT;

AMYLOID; ANIMALS; ARGININE; GLUCOSE; IMMUNOHISTOCHEMISTRY; INSULIN; INSULIN ANTAGONISTS; ISLETS OF LANGERHANS; MALE; RADIOIMMUNOASSAY; RATS; RATS, SPRAGUE-DAWLEY; SOMATOSTATIN; SOMATOSTATIN-SECRETING CELLS;

ANIMALIA;

EID: 0030728818     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(97)01037-9     Document Type: Article

References (34)

1. Westermark P., Wernstedt C., Wilander E., Hayden D.W., O'Brien T.D., Johnson K.H. Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci USA. 84:1987;3881-3885.
2. Westermark P., Wernstedt C., Wilander E., Sletten K. A novel peptide in the calcitonin gene related peptide family as an amyloid fibril protein in the endocrine pancreas. Biochem Biophys Res Commun. 140:1986;827-831.
3. Cooper G.J.S., Willis A.C., Clark A., Turner R.C., Sim R.B., Reid K.B.M. Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci USA. 84:1987;8628-8632.
4. Johnson K.H., O'Brien T.D., Hayden D.W., Jordan K., Ghobrial H.K.G., Mahoney W.C., Westermark P. Immunolocalization of islet amyloid polypeptide (IAPP) in pancreatic beta cells by means of peroxidase-antiperoxidase (PAP) and protein A-gold techniques. Am J Pathol. 130:1988;1-8.
5. Stridsberg M., Sandler S., Wilander E. Cosecretion of islet amyloid polypeptide (IAPP) and insulin from isolated rat pancreatic islets following stimulation or inhibition of β-cell function. Regul Pept. 45:1993;363-370.
6. Moore C.X., Cooper G.J.S. Co-secretion of amylin and insulin from cultured islet β-cells: modulation by nutrient secretagogues, islet hormones and hypoglycemic agents. Biochem Biophys Res Commun. 179:1991;1-9.
7. Ohsawa H., Kanatsuka A., Yamaguchi T., Makino H., Yoshida S. Islet amyloid polypeptide inhibits glucose-stimulated insulin secretion from isolated rat pancreatic islets. Biochem Biophys Res Commun. 160:1989;961-967.
8. Wang Z.L., Bennet W.M., Ghatei M.A., Byfield P.G.H., Smith D.M., Bloom S.R. Influence of islet amyloid polypeptide and the 8-37 fragment of islet amyloid polypeptide on insulin release from perifused rat islets. Diabetes. 42:1993;330-335.
9. Fürnsinn C., Leuvenink H., Roden M., Nowotny P., Schneider B., Rohac M., Pieber T., Clodi M., Waldhäusl W. Islet amyloid polypeptide inhibits insulin secretion in conscious rats. Am J Physiol. 267:1994;E300-305.
10. Fehmann H.C., Weber V., Göke R., Göke B., Eissele R., Arnold R. Islet amyloid polypeptide (IAPP; amylin) influences the endocrine but not the exocrine rat pancreas. Biochem Biophys Res Commun. 167:1990;1102-1108.
11. Pettersson M., Ahrén B. Failure of islet amyloid polypeptide to inhibit basal and glucose-stimulated insulin secretion in model experiments in mice and rats. Acta Physiol Scand. 138:1990;389-394.
12. Broderick C.L., Brooke G.S., DiMarchi R.D., Gold G. Human and rat amylin have no effects on insulin secretion in isolated rat pancreatic islets. Biochem Biophys Res Commun. 177:1991;932-938.
13. Nagamatsu S., Carroll R.J., Grodsky G.M., Steiner D.F. Lack of islet amyloid polypeptide regulation of insulin biosynthesis or secretion in normal rat islets. Diabetes. 39:1990;871-874.
14. Bretherton-Watt D., Gilbey S.G., Ghatei M.A., Beacham J., Bloom S.R. Failure to establish islet amyloid polypeptide (amylin) as a circulating beta cell inhibiting hormone in man. Diabetologia. 33:1990;115-117.
15. Ar'Rajab A., Ahrén B. Effects of amidated rat islet amyloid polypeptide on glucose-stimulated insulin secretion in vivo and in vitro in rats. Eur J Pharmacol. 192:1991;443-445.
16. Ohtsuka H., Iwanaga T., Fujino M.A., Fujita T. Amylin-containing cells in the gastro-entero-pancreatic (GEP) endocrine system of the rat and humans - An immunohistochemical study. Acta Histochem Cytochem. 26:1993;405-414.
17. Ahrén B., Sundler F. Localization of calcitonin gene-related peptide and islet amyloid polypeptide in the rat and mouse pancreas. Cell Tissue Res. 269:1992;315-322.
18. Itoh M., Mandarino L., Gerich J.E. Antisomatostatin gamma globulin augments secretion of both insulin and glucagon in vitro. Diabetes. 29:1980;693-696.
19. Patel Y.C., Pierzchala I., Amherdt M., Orci L. Effects of cysteamine and antibody to somatostatin on islet cell function in vitro. J Clin Invest. 75:1985;1249-1255.
20. Malm D., Vonen B., Burhol P.G., Florholmen J. The interaction between cAMP-dependent and cAMP-independent mechanisms in mediating the somatostatin inhibition of insulin secretion in isolated rat pancreatic islets. Acta Physiol Scand. 143:1991;305-310.
21. Bonner-Weir S. Anatomy of the islet of Langerhans. In: Samols E, editors. The Endocrine Pancreas. New York: Raven Press, 1991:15-27.
22. Andersson A. Isolated mouse pancreatic islets in culture: effects of serum and different culture media on the insulin production of the islets. Diabetologia. 14:1978;397-404.
23. Welsh N., Hellerström C. In vitro restoration of insulin production in islets from adult rats treated neonatally with streptozotocin. Endocrinology. 126:1990;1842-1848.
24. Westermark G., Benig-Arora M., Fox N., Carroll R., Chan S.J., Westermark P., Steiner D.F. Amyloid formation in response to b cell stress occurs in vitro, but not in vivo, in islets of transgenic mice expressing human islet amyloid polypeptide. Mol Med. 1:1995;542-553.
25. Lacy P.E., Kostianovsky M. Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes. 16:1967;35-39.
26. 2+ for the effects of cholecystokinin-8 in rat pancreatic islets. Diabetes Res. 16:1991;139-143.
27. Baetens D., Malaisse-Lagae F., Perrelet A., Orci L. Endocrine pancreas: Three-dimensional reconstruction shows two types of islets of Langerhans. Science. 206:1979;1323-1325.
28. Levin S.R., Karam J.H., Hane S., Grodsky G.M., Forsham P.H. Enhancement of arginine-induced insulin secretion in man by prior administration of glucose. Diabetes. 20:1971;171-176.
29. Inoue K., Hisatomi A., Umeda F., Nawata H. Effects of exogenous somatostatin and insulin on islet amyloid polypeptide (amylin) release from perfused rat pancreas. Horm Metab Res. 24:1992;251-253.
30. Panagiotidis G., Salehi A.A., Westermark P., Lundquist I. Homologous islet amyloid polypeptide: effects on plasma levels of glucagon, insulin and glucose in the mouse. Diabetes Res Clin Pract. 18:1992;167-171.
31. Nagamatsu S., Nishi M., Steiner D.F. Effects of islet amyloid polypeptide (IAPP) on insulin biosynthesis or secretion in rat islets and mouse βTC3 cells Biosynthesis of IAPP in mouse βTC3 cells. Diabetes Res Clin Pract. 15:1992;49-56.
32. Draznin B., Leitner J.W., Sussman K.E. A unique control mechanism in the regulation of insulin secretion. J Clin Invest. 75:1985;1510-1516.
33. Pettersson M., Ahrén B. Insulin and glucagon secretion in rats: effects of calcitonin gene-related peptide. Regul Pept. 23:1988;37-50.
34. Inoue K., Hiramatsu S., Hisatomi A., Umeda F., Nawata H. Effects of Amylin on the release of insulin and glucagon from the perfused rat pancreas. Horm Metab Res. 25:1993;135-137.